AS1411-GNP

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAS1411-GNP
Drug Alias NameAptamer-Linked Anti-NucleolinALAN
ClassificationBiologics
Mechanisms of ActionNucleolin inhibitors
TargetsNucleolin
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Louisville
China Registration ClassN/A

Develop Information

Active CompaniesQualigen Sl
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A